Taurocholic Acid sodium hydrate

• CAT Number: I003264
• CAS Number: 345909-26-4
• Molecular Formula: C26H46NNaO8S
• Molecular Weight: 555.70
• Purity: ≥95%
• Target: Endogenous Metabolite
• Solubility: H2O: 50 mg/mL
• Storage: 3 years -20C powder
• IUPAC Name: sodium;2-[[(4R)-4-[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonate;hydrate
• InChI: InChI=1S/C26H45NO7S.Na.H2O/c1-15(4-7-23(31)27-10-11-35(32,33)34)18-5-6-19-24-20(14-22(30)26(18,19)3)25(2)9-8-17(28)12-16(25)13-21(24)29;;/h15-22,24,28-30H,4-14H2,1-3H3,(H,27,31)(H,32,33,34);;1H2/q;+1;/p-1/t15-,16+,17-,18-,19+,20+,21-,22+,24+,25+,26-;;/m1../s1
• InChIKey: RDAJAQDLEFHVNR-NEMAEHQESA-M
• SMILES: CC(CCC(=O)NCCS(=O)(=O)[O-])C1CCC2C1(C(CC3C2C(CC4C3(CCC(C4)O)C)O)O)C.O.[Na+]

Taurocholic Acid Sodium Hydrate（Cat No.:I003264）is a high-purity bile acid derivative crucial for advanced biochemical and pharmaceutical research. As a key component in the emulsification and absorption of fats, it plays a significant role in studying lipid metabolism and liver function. This isotopically labeled compound provides precise and reliable analytical results, enhancing the accuracy of metabolic and pharmacokinetic studies. Its high stability and consistency make it ideal for various experimental setups, ensuring robust and cost-effective scientific investigations in drug development and metabolic research.